Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity
- PMID: 101464
- PMCID: PMC421960
- DOI: 10.1128/iai.21.1.76-86.1978
Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity
Abstract
The preparation, properties, and immunogenicity of ribosomal vaccines from Pseudomonas aeruginosa are described. These preparations, containing protein and RNA, were tested for immunogenicity by active immunization of mice and subsequent challenge with homologous, live bacteria. The results demonstrated that vaccines prepared from a majority of serotypes used were immunogenic, i.e., afforded 60 to 100% mouse protection against a challenge inoculum containing 8 to 50 50% lethal doses. In some cases vaccine doses as low as 1 microgram of RNA provided 100% mouse protection. Molecular sieve chromatography of a highly immunogenic ribosomal preparation on Sepharose 4B demonstrated the presence of two molecular weight fractions: (i) peak A, an excluded peak (thus having a molecular weight of at least 2 times 10(7)), and (ii) peak B, considerably retarded, with an elution position corresponding to a molecular weight of about 2.2 X 10(6), approximating that of typical 70S ribosomes. Both peaks A and B were immunogenic; however, the immunogenicity of peak A was greater (i.e., a smaller immunizing dose was required) than that of peak B. Peak A was shown to contain components of lipopolysaccharide in addition to protein and RNA (which comprised 80% of the dry weight of peak A). On the other hand, peak B was shown to be free of lipopolysaccharide, and 100% of its dry weight consisted of protein and RNA.
Similar articles
-
Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.Infect Immun. 1979 Feb;23(2):509-21. doi: 10.1128/iai.23.2.509-521.1979. Infect Immun. 1979. PMID: 106013 Free PMC article.
-
Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.Infect Immun. 1981 Jul;33(1):178-85. doi: 10.1128/iai.33.1.178-185.1981. Infect Immun. 1981. PMID: 6167518 Free PMC article.
-
Ribonuclease-sensitive ribosomal vaccines.Antonie Van Leeuwenhoek. 1984;50(5-6):763-74. doi: 10.1007/BF02386239. Antonie Van Leeuwenhoek. 1984. PMID: 6084981
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
-
Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.Expert Rev Vaccines. 2005 Oct;4(5):645-56. doi: 10.1586/14760584.4.5.645. Expert Rev Vaccines. 2005. PMID: 16221066 Review.
Cited by
-
Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.Infect Immun. 1981 Mar;31(3):896-905. doi: 10.1128/iai.31.3.896-905.1981. Infect Immun. 1981. PMID: 6785242 Free PMC article.
-
Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.Infect Immun. 1980 Jan;27(1):204-10. doi: 10.1128/iai.27.1.204-210.1980. Infect Immun. 1980. PMID: 6153637 Free PMC article.
-
Immunogenicity of ribosomal preparations from Neisseria gonorrhoeae.Infect Immun. 1980 Apr;28(1):92-100. doi: 10.1128/iai.28.1.92-100.1980. Infect Immun. 1980. PMID: 6769823 Free PMC article.
-
Immunogenicity of ribosomes from enzymatically lysed Streptococcus pyogenes.Infect Immun. 1980 Feb;27(2):424-30. doi: 10.1128/iai.27.2.424-430.1980. Infect Immun. 1980. PMID: 6155333 Free PMC article.
-
Role of outer envelope contamination in protection elicited by ribosomal preparations against Neisseria gonorrhoeae infection.Infect Immun. 1981 Apr;32(1):173-9. doi: 10.1128/iai.32.1.173-179.1981. Infect Immun. 1981. PMID: 7216484 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources